VICI vs ZYME · P/E 9.3, rev $3.85B vs rev $76.3M
VICI Properties Inc (VICI) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
VICI Properties Inc (VICI) is a reit - diversified company listed on NYSE.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported VICI revenue for 2024-12-31 was $3.85B. Net income was $2.72B. Revenue was up 6.6% from 2023-12-31 to 2024-12-31. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
VICI currently screens at market cap $29.32B and trailing P/E 9.3. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the VICI and ZYME stock pages for the full models.
Not investment advice.